Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor

Human Gene Therapy

Volumn 8, Issue 3, 1997, Pages 331-339

  Lin, Qing ^a   Cunningham, Lee A ^a,c   Epstein, Leon G ^a   Pechan, Peter A ^b   Short, M Priscilla ^b   Fleet, Christina ^b   Bohn, Martha C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR BETA SUBUNIT;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL ISOLATION; CHROMAFFIN CELL; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; FETUS CELL; GENE; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PROTEIN SECRETION; RAT; RETROVIRUS; TRANSGENE;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0030816512     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.3-331     Document Type: Article

References (61)

1. AEBISCHER, P., SCHLUEP, M., DEGLON, N., JOSEPH, M., HIRT, L., HEYD, B., HAMMANG, J.P., ZURN, A.D., KATO, A.C., REGLI, F., and BAETGE, E.E. (1996). Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med. 2, 696-699.
2. ALOE, L., and LEVI-MONTALCINI, R. (1979). Nerve growth factor-induced transformation of immature chromaffin cells in vivo into sympathetic neurons: Effect of antiserum to nerve growth factor. Proc. Natl. Acad. Sci. USA 76, 1246-1250.
3. BACKLUND, E.O., GRANBERG, P.O., HAMBERGER, B., KNUTSSON, E., MARTENSSON, A., SEDVALL, G., SEIGER, A., and OLSON, L. (1985). Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J. Neurosurg. 62, 169-173.
4. BAKAY, R.A.E. (1992). Central nervous system grafting: animal and clinical results. Stereotactic & Funct. Neurosurg. 58, 67-78.
5. CASTEL-BARTHE, M.N., JAZAT-POINDESSOUS, F., BARNEOUD, P., VIGNE, E., REVAH, F., MALLET, J., and LAMOUR, Y. (1996). Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: Effect on basal forebrain cholinergic neurons during aging. Neurobiol. Disease 3, 76-86.
6. CASTILLO, B., JR., DEL CERRO, M., BREAKEFIELD, X.O., FRIM, D.M., BARNSTABLE, C.J., DEAN, D.O., and BOHN, M.D. (1994). Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF). Brain Res. 647, 30-36.
7. CEPKO, C. (1989). Lineage analysis and immortalization of neural cells via retrovirus vectors. In Molecular Neurobiological Techniques, Neuromethods. A.A. Boulton, G.B. Baker and A.T. Campagnoni, eds. (Humana, Clifton, NJ) pp. 177-219.
8. CHEN, K.S., and GAGE, F.H. (1995). Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration. J. Neurosci. 15, 2819-2825.
9. CHIRGWIN, J.M., PRZYBYLA, A.E., MACDONALD, R.J., and RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
10. CHOI-LUNDBERG, D.L., LIN, Q., CHANG, Y.-N., CHIANG, Y.L., HAY, C.M., MOHAJERI, H., DAVIDSON, B.L., and BOHN, M.C. (1997). Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science (in press).
11. CLAUDE, P., CLAUDE, P., PARADA, I.M., GORDON, K.A., D'AMORE, P.A., and WAGNER, J.A. (1988). Acidic fibroblast growth factor stimulates adrenal chromaffin cells to proliferate and to extend neurites, but is not a long-term survival factor. Neuron 1, 783-790.
12. CUNNINGHAM, L.A., HANSEN, J.T., SHORT, M.P., and BOHN, M.C. (1991a). The use of genetically altered astrocytes to provide nerve growth factor (NGF) to adrenal chromaffin cells grafted into the striatum. Brain Res. 561, 192-202.
13. CUNNINGHAM, L.A., SHORT, M.P., VIELKIND, U., BREAKEHELD, X.O., and BOHN, M.C. (1991b). Rat pheochromocytoma (PC12) cells carrying the mouse β-NGF gene survive and differentiate following implantation into the adult mouse striatum. Exp. Neurol. 112, 174-182.
14. CUNNINGHAM, L.A., SHORT, M.P., BREAKEFIELD, X.O., and BOHN, M.C. (1994). Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease. Brain Res. 658, 219-231.
15. DANOS, O., and MULLIGAN, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464.
16. DOUPE, A.J., LANDIS, S.C., and PATTERSON, P.H. (1985). Environmental influences in the development of neural crest derivatives: Glucocorticoids, growth factors and chromaffin cell plasticity. J. Neurosci. 5, 2119-2142.
17. DURING, M.J., NAEGELE, J.R., O'MALLEY, K.L., and GELLER, A.I. (1994). Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
18. EMERICH, D.F., WINN, S.R., HARPER, J., HAMMANG, J.P., BAETGE, E.E., and KORDOWER, J.H. (1994b). Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J. Comp. Neurol. 349, 148-164.
19. ERNFORS, P., EBENDAL, T., OLSON, L., MOUTON, P., STRÖMBERG, I., and PERSSON, H. (1989). A cell line producing recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons. Proc. Natl. Acad. of Sci. USA 86, 4756-4760.
20. FEDEROFF, H.J., GESCHWIND, M.D., GELLER, A.I., and KESSLER, J.A. (1992). Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. of Sci. USA 89, 1636-1640.
21. FREED, W.J., POLTORAK, M., and BECKER, J.B. (1990). Intracerebral adrenal medulla grafts: A review. Exp. Neurol. 110, 139-166.
22. FRIDEN, P.M., WALUS, L.R., WATSON, P., DOCTROW, S.R., KOZARICH, J.W., BACKMAN, C., BERGMAN, H., HOFFER, B., BLOOM, F., and GRANHOLM, A.-C. (1993). Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259, 373-377.
23. GAGE, F.H., WOLFF, J.A., ROSENBERG, M.B., XU, L., YEE, J.-K., SHULTS, C., and FRIEDMANN, T. (1987). Grafting genetically modified cells into the brain: Possibilities for the future. Neuroscience 23, 795-807.
24. GOFF, S., TRAKTMAN, P., and BALTIMORE, D. (1981). Isolation and properties of moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38, 239-248.
25. GRANHOLM, A.C., BÄCKMAN, C., HOFFER, B., WALUS, L., BLOOM, F., and FRIDEN, B. (1992). Nerve growth factor conjugated to an anti-transferrin receptor antibody crosses the blood brain barrier as evidenced by functional effects on intraocular septal transplants. Restor. Neurol. Neurosci. 4, 195.
26. HEFTI, F. (1986). Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6, 2155-2162.
27. HOFFMAN, D., BREAKEFIELD, X.O., SHORT, M.P., and AEBISCHER, P. (1993). Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp. Neurol. 122, 100-103.
28. HYMAN, C., HOFER, M., BARDE, Y.-A., JUHASZ, M., YANCOPOULOS, G.D., SQUINTO, S.P., and LINDSAY, R.M. (1991). BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
29. JIAO, S., GUREVICH, V., and WOLFF, J.A. (1993). Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362, 450-455.
30. KAPLITT, M., KWONG, A., LEOPOULOS, S., MOBBS, C., RABKIN, S., and PFAFF, D. (1994). Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc. Natl. Acad. Sci. USA 91, 8979-8983.
31. KAWAJA, M.D., and GAGE, F.H. (1991). Reactive astrocytes are substrates for the growth of adult CNS axons in the presence of elevated levels of nerve growth factor. Neuron 7, 1019-1030.
32. KORDOWER, J., MUFSON, E., GRANHOLM, A., HOFFER, B., and FRIDEN, P. (1993). Delivery of trophic factors to the primate brain [review]. Exp. Neurol. 124, 21-30.
33. KORDOWER, J.H., FREEMAN, T.B., SNOW, B.J., VINGERHOETS, R.J.G., MUFSON, E.J., SANBER, P.R., HAUSER, R.A., SMITH, D.A., NAUERT, G.M., PERL, D.P., and OLANOW, C.W. (1995). Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med 332, 1118-1124.
34. LIN, L.-F.H., DOHERTY, D.H., LILE, J.D., BEKTESH, S., and COLLINS, F. (1993). GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
35. LINDNER, M.D., WINN, S.R., BAETGE, E.E., HAMMANG, J.P., GENTILE, F.T., DOHERTY, E., MCDERMOTT, P.E., FRYDEL, B., ULLMAN, M.D., SCHALLERT, T., and EMERICH, D.F. (1995). Implantation of encapsulated catecholamine and GDNF producing cells in rats with unilateral dopamine depletions and Parkinsonian symptoms. Exp. Neurol. 132, 62-76.
36. LUCIDI-PHILLIPI, C.A., GAGE, F.H., SHULTS, C.W., JONES, K.R., REICHARDT, L.F., and KANG, U.J. (1995). Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain. J. Comp. Neurol. 354, 361-376.
37. MADRAZO, I.M., DRUCKER-COLIN, R., DIAZ, V., MARTINEZ-MATA, J., TORRES, C., and BECERRIL, J.J. (1987). Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 316, 831-834.
38. MARTINEZ-SERRANO, A., LUNDBERG, C., HORELLOU, P., FISCHER, W., BENTLAGE, C., CAMPBELL, K., MCKAY, R.D.G., MALLET, J., and BJORKLUND, A. (1995a). CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain-complete rescue of axotomized cholinergic neurons after transplantation into the septum. J. Neurosci. 15, 5668-5680.
39. MARTINEZ-SERRANO, A., LUNDBERG, C., HORELLOU, P., FISCHER, W., BENTLAGE, C., CAMPBELL, K., MCKAY, R.D.G., MALLET, J., and BJORKLUND, A. (1995b). CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: complete rescue of axotomized cholinergic neurons after transplantation into the septum. J. Neurosci. 15, 5668-5680.
40. MCCARTHY, K.D., and DEVELLIS, J. (1980). Preparation of separate astroglial and oligodendroglial cell cultures from cerebral tissue. J. Cell Biol. 85, 890-902.
41. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
42. NOBEL, M., FOK-SEAN, J., and COEHN, J. (1984). Glia are a unique substrate for the in vitro growth of central nervous system neurons. J. Neurosci. 4, 1892-1903.
43. OLSON, L., BACKLUND, E.O., EBENDAL, T., FREEDMAN, R., and AL, E. (1991). Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. Arch. Neurol. 48, 373-381.
44. POWELL, E.M., SOBARZO, M.R., and SALTZMAN, W.M. (1990). Controlled release of nerve growth factor from a polymeric implant. Brain Res. 515, 309-311.
45. PUNDT, L.L., KONDOH, T., and LOW, W.C. (1995). The fate of human glial cells following transplantation on normal rodents and rodent models of neurodegenerative disease. Brain Res. 695, 25-36.
46. RIDET, J.-L., and PRIVAT, A. (1995). Gene therapy in the central nervous system: Direct versus indirect gene delivery. J. Neurosci. Res. 42, 287-293.
47. ROSENBERG, M.B., FRIEDMANN, T., ROBERTSON, R.C., TUSZYNSKI, M., WOLFF, J.A., BREAKEFIELD, X.O., and GAGE, F.H. (1988). Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242, 1575-1578.
48. RUDGE, J.S., MANTHORPE, M., and VARON, S. (1985). The output of neuronotrophic and neurite-promoting agents from rat brain astroglial cells: a microculture method for screening potential regulatory molecules. Dev. Brain Res. 19, 161-172.
49. SCOTT, J., SELBY, M., URDEA, M., QUIROGA, M., BELL, G.I., and RUTTER, W.J. (1983). Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature 302, 538-540.
50. SHORT, M.P., ROSENBERG, M.B., EZZEDINE, Z.D., GAGE, F.H., FRIEDMANN, T., and BREAKEFIELD, X.O. (1990). Autocrine differentiation of PC12 cells mediated by retroviral vectors. Dev. Neurosci. 12, 34-45.
51. STEMPLE, D.L., MAHANTHAPPA, N.K., and ANDERSON, D.J. (1988). Basic FGF induced neuronal differentiation, cell division, and NGF dependence in chromaffin cells: A sequence of events in sympathetic development. Neuron 1, 5972-5982.
52. STRÖMBERG, I., HERRERA-MARSCHITZ, M., UNGERSTEDT, U., EBENDAL, T., and OLSON, L. (1985). Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp. Brain Res. 60, 335-349.
53. STRÖMBERG, I., WETMORE, C.J., EBENDAL, T., ERNFORS, P., PERSSON, H., and OLSON, L. (1990). Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J. Neurosci. Res. 25, 405-411.
54. TUSZYNSKI, M.H., U, H.S., AMARAL, D.G., and GAGE, F.H. (1990). Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 10, 3504-3614.
55. TUSZYNSKI, M.H., PETERSON, D.A., RAY, J., BAIRD, A., NAKAHARA, Y., and GAGE, F.H. (1994). Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp. Neurol. 126, 1-14.
56. TUSZYNSKI, M.H., ROBERTS, J., SENUT, M.C., U, H.S., and GAGE, F.H. (1996). Gene therapy in the adult primate brain - intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther. 3, 305-314.
57. UNSICKER, K., KIRSCH, B., OTTEN, U., and THOENEN, H. (1978). Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: Impairment by glucocorticoids. Proc. Natl. Acad. Sci. USA 75, 3498-3502.
58. UNSICKER, K., REICHERT-PREIBSCH, H., SCHMIDT, R., PETTMANN, B., LABOURDETTE, G., and SENSENBRENNER, M. (1987). Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons. Proc. Natl. Acad. Sci. USA 84, 5459-5463.
59. VAHLSING, H.L., VARON, S., HAGG, T., FASS-HOLMES, B., DEKKER, A., MANLEY, M., and MANTHORPE, M. (1989). An improved device for continuous intraventricular infusions prevents the introduction of pump-derived toxins and increases the effectiveness of NGF treatments. Exp. Neurol. 105, 233-243.
60. WHITTEMORE, S.R., FRIEDMAN, P.L., LARHAMMAR, D., PERSSON, H., GONZALEZ-CARVAJAL, M., and HOLETS, V.R. (1988). Rat β-nerve growth factor sequence and site of synthesis in the adult hippocampus. J. Neurosci. Res. 20, 403-410.
61. YOSHIMOTO, Y., LIN, Q., COLLIER, T., FRIM, D., BREAKEFIELD, X.O., and BOHN, M.C. (1995). Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691, 25-36.